Academic Medicine wiki-based narrative
This exhibit is supplementary to the manuscript It’s Time to Wikify Clinical Documentation: How Collaborative Authorship Can Reduce the Burden and Improve the Quality of the Electronic Health Record.
The purpose of this page is to illustrate how a wiki-based clinical document might appear; the content is based on a series of synthetic notes that can found here. These notes are completely synthetic and any resemblance to a real patient is entirely coincidental. Text versions of the notes can be accessed here.
Note: some of the links below are to external websites such as Wikipedia and the NCI Thesaurus. In a true medical wiki, these external links would likely be replaced with application programming interfaces (APIs), which would enforce HIPAA-compliant authentication and authorization.
Demographics
Note: the linked "Sex" is to a value set that specifies a set of structured choices from the FHIR AdministrativeGender value set, as an example of how wiki-based formatting can be linked to structured concepts. Likewise, the "Race" and "Ethnicity" concepts can be linked directly to the CDC Race and Ethnicity Code Set Version 1.0, which is required for certified EHRs. Note also that some versions of wiki software can calculate dates, such as the current age based on DOB (not currently enabled here).
- Patient Name: PatientX
- Sex: Female
- DOB: January 1, 1960
- Race: White (2106-3)
- Ethnicity: Not Hispanic or Latino (2186-5)
- Note that "concept codes" such as 2106-3 do not have to be shown, and can be toggled/hidden.
Active medical problems
This is the core of the medical wiki and could be arranged by subheadings, as here, or across multiple linked pages. Each active problem can be split into multiple sub-headings, such as the diagnosis and treatment subheadings here.
Breast carcinoma
Diagnosis
This section illustrates the use of a standard wikitable for the various diagnostic procedures. Also illustrated is the use of color to specify which author has added the content: blue = radiologist; green = medical oncologist
- HPI: In early 2010, she noticed a hard palpable lump in her left breast and sought medical attention. She has been adherent to a schedule of annual mammography since age 40, last in 2009 and normal. No particular family history of breast cancer. She denies weight loss, change in appetite, jaundice, fatigue, or focal pain.
Date | Procedure | Findings |
---|---|---|
2010/01/21 | Full field digital mammography with CAD was performed including routine views of both breasts, spot magnification views on the right with a full 90 degree lateral and spot compression views on the left. | Heterogeneously dense fibroglandular tissue is present throughout both breasts limiting the sensitivity of the mammogram. There is no evidence of mass or calcifications in the right breast.
|
2010/01/21 | Left breast and axillary ultrasound | A large hypoechoic mass at the 10:30 location of the left breast is highly suggestive of a malignancy. The mass measures 1.2x3.4x5.6 cm.
|
2010/02 | CT A/P | negative for metastatic disease |
Prognosis
This cancer-specific section illustrates the use of a standard wikitable to summarize stage, and highlighting to emphasize pertinent biomarker information.
Modality | AJCC Edition | T-stage | N-stage | M-stage | Summary stage |
---|---|---|---|---|---|
Clinical | 7th | cT3 | cN1 | cM0 | IIIA |
Pathologic | 7th | ypT1a | ypN1 | ypM0 | IIA |
- More information at Cancer.net
- Other prognostic factors:
- Nottingham score: 8/9
- Surgical margins: Negative
- Response to neoadjuvant therapy: Grade 3 per the Miller Payne scoring system
- Biomarkers: ER/PR/HER2-negative (triple-negative)
Treatment
Neoadjuvant therapy
These links go directly to details about the drugs, doses, and schedules used in these treatments.
Definitive therapy
- 2010/06/30: Left modified radical mastectomy
Postoperative therapy
- Observation
Current status
- 2018/06/15: No evidence of disease
Diabetes mellitus type 2
Diagnosis
- First noted to have gestational diabetes during her second pregnancy, at age 32. At age 43, she met the definition of DM2.
Treatment
Note that by linking to the medication list below, details do not necessarily need to be repeated here. Wikis also have the ability to bring external information such as lab results into the page through a process called transclusion, which could be employed here for the A1c.
Current
- 2005- Metformin, with last HgbA1c = 6.0%
Previous
- 2003-2005: Diet and exercise
Hypertension
Diagnosis
- Initially noticed to have white-coat hypertension at age 42, developed into hypertension by age 46 per JNC Guidelines
Treatment
Note that by linking to the medication list below, details do not necessarily need to be repeated here.
Current
- 2008- Lisinopril, with excellent BP control
Previous
- 2002-2005: Diet and exercise
- 2005-2008: HCTZ for 3 years, initially effective but then was no longer working
Resolved medical problems
Peripheral neuropathy
Notice how this problem is linked to the drug that caused it (on a separate page) and to the disease for which it was used.
- Cause: Paclitaxel (Taxol) chemotherapy, given for breast cancer
- Treatment: removal of paclitaxel from the treatment regimen
- Resolution: nearly complete, with some minor residual tingling in the fingertips
Allergies
- Morphine
- Category: Medication
- Reaction: Maculopapular rash
- Level of certainty: Confirmed
Medications
This section illustrates a sortable table, which can be re-arranged by clicking on any of the columns. Notice that each drug name is linked to the structured concept of that drug in the RxNorm ontology, and some indications are linked back to the problem list section of the wiki. Here, aspirin is labeled as an NSAID, which is technically true but may not reflect the prescribed purpose. A user could update this drug class to anti-platelet medication.
Class of drug | Drug | Dose | Route | Frequency | Scheduled or prn | Indication |
---|---|---|---|---|---|---|
Anti-diabetic | Metformin | 500 mg | PO | once per day | Scheduled | T2 DM |
Anti-hypertensive | Lisinopril | 5 mg | PO | once per day | Scheduled | HTN |
NSAID | Aspirin | 81 mg | PO | once per day | Scheduled | Primary prevention of MI/CVA |
Anti-emetic | Ondansetron | 4 mg | ODT | TID | prn | Prevention of CINV |
Family history
- Mother: living, with dementia
- Father: d. of cerebral aneurysm, age 64
- Sister #1: alive and well
- Sister #2: alive and well
Social history
Alcohol
- Occasional drinks
Tobacco
- Former smoker
- Smoked 1/2 PPD x 5 years
- Quit 20 years ago